Table 1.
Descriptive Statistical Data of Various Parameters in the 3 Studied Groups
| group I | Group II | group III | |
|---|---|---|---|
| HCC (n=30) | liver cirrhosis (n=20) | Healthy Control (n=20) | |
| HG (gm/dl) Mean ± SD | 8.16 ±1.5 | 8.6 ± 0.7 | 12.6 ± 0.7 |
| Platelets (x103/mm3) Mean ± SD | 103.1 ± 15.9 | 113.3 ±1 2.5 | 199.4 ± 23.9 |
| ALT (U/l) Mean ± SD | 61.2 ± 18.7 | 65.9 ± 20.8 | 27.1 ± 3.8 |
| AST (U/l) Mean ± SD | 66.9 ± 19.5 | 69.7 ± 20.2 | 28.2 ± 5.3 |
| T. Bil (mg/dl) Mean ± SD | 3.3 ± 0.8 | 3.2 ± 0.9 | 0.9 ± 0.1 |
| Creatinine (mg/dl) Mean ± SD | 1.8 ± 0.9 | 1.7 ± 0.9 | 0.9 ± 0.3 |
| INR: Mean ± SD | 1.3±0.5 | 1.2 ± 0.6 | 0.9 ± 0.2 |
| Albumin (gm/dl) Mean ± SD | 2.5 ± 0.4 | 2.6 ± 0.3 | 4.1 ± 0.4 |
| ANXA4 (ng/ml)Median | 188 | 23 | 21 |
| IQR | (42 - 428) | (24 - 33) | (22 - 24) |
| AFP < 200 ng/ml (No of patients) | 6 (20%) | 17 (85%) | 20 (100%) |
| AFP ≥ 200 ng/ml (No of patients) | 24 (80 %) | 3 (15%) | 0 (0%) |
HG, hemoglobin; IQR, inter quartile ratio; AFP, alpha fetoprotein; No, number; HCC, Hepatocellular carcinoma; T. Bil, total bilirubin; AST, aspartate transaminase; ALT, alanine transaminase; INR, international normalization ratio